Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) Stock Information | RedChip

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX)


$7.9900
+0.1400 ( -0.25% ) 367.0K

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Market Data


Open


$7.9900

Previous close


$7.8500

Volume


367.0K

Market cap


$2.47B

Day range


$7.5800 - $8.1000

52 week range


$5.0100 - $9.4750

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 26, 2024
4 Insider transactions 1 Nov 25, 2024
4 Insider transactions 1 Nov 22, 2024
4 Insider transactions 1 Nov 19, 2024
8-k/a 8K-related 15 Nov 12, 2024
10-q Quarterly Reports 103 Nov 12, 2024
8-k 8K-related 3 Nov 08, 2024
8-k 8K-related 17 Oct 01, 2024
4 Insider transactions 1 Aug 16, 2024
4 Insider transactions 1 Aug 16, 2024

Latest News